ACAD: To Present At Thomas Weisel Healthcare Conference @ 14:40 ET [delayed] -
ACAD: Q2 Earnings Call @ 17:00 ET Today [delayed] -
Acadia reports loss in Q2, plans to cut 50% jobs -
ACADIA Pharmaceuticals Secures Committed Equity Financing Facility -
ACADIA Pharmaceuticals Announces Second Quarter 2008 Financial Results and Strategic Restructuring -
ACAD: Q2 Earnings Call @ 08:30 ET Today [delayed] -
ACAD hits 52-week low at 3.04 -
ACADIA Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008 -
ACADIA Pharmaceuticals Inc (ACAD) Corporate Event Announcement Notice -
ACADIA Pharmaceuticals Inc (ACAD) Corporate Event Announcement Notice -
Acadia Pharmaceuticals advances after Banc of America upgrades to neutral -
ACAD: To Present At Jefferies Healthcare Conference @ 08:00 ET [delayed] -
Acadia's schizophrenia drug fails study end point -
Acadia Pharma downgraded to sell at Banc of America; price target cut to $3.50 -
Acadia Pharma: ACP-104 Phase IIb schizophrenia trail missed primary endpoint -
Acadia Pharmaceuticals Closes At New Low On Failed Drug Trial -